Strategic partnerships Leverage ongoing collaborations with Atelier Health and Mount Sinai to co-develop AI-enhanced ECG solutions and expand remote monitoring capabilities, unlocking joint selling opportunities to hospitals, clinics, and concierge medical practices.

Expanded geographic footprint capitalize on the California expansion and existing New York metro, Dallas, and South Florida markets to accelerate commercial deployments of the cable-free 3D ECG system among cardiology groups, urgent care networks, and digital health platforms.

AI driven offerings Promote the AI-based ECG algorithms and 12-lead patch pilot to health systems seeking advanced predictive analytics and early intervention capabilities, targeting enterprise contracts with integrated AI cardiology workflows.

Regulatory edge Highlight FDA clearance for 3D ECG arrhythmia assessment as a differentiator at procurement discussions, aligning with buyers prioritizing compliant, clinically validated remote monitoring solutions.

Financial and growth signals Position the company’s mid-market revenue trajectory and available funding as a basis for scalable pilots and phased deployments, appealing to mid-sized hospitals and multisite clinics looking for innovative, cost-effective cardiac care tech.